1. Home
  2. TUSK vs BMEA Comparison

TUSK vs BMEA Comparison

Compare TUSK & BMEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mammoth Energy Services Inc.

TUSK

Mammoth Energy Services Inc.

HOLD

Current Price

$3.12

Market Cap

137.3M

Sector

Energy

ML Signal

HOLD

Logo Biomea Fusion Inc.

BMEA

Biomea Fusion Inc.

N/A

Current Price

$1.70

Market Cap

115.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TUSK
BMEA
Founded
2014
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Oilfield Services/Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
137.3M
115.2M
IPO Year
2016
2021

Fundamental Metrics

Financial Performance
Metric
TUSK
BMEA
Price
$3.12
$1.70
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$9.83
AVG Volume (30 Days)
231.4K
1.4M
Earning Date
05-11-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
102.32
69.19
EPS
0.09
N/A
Revenue
$44,292,000.00
N/A
Revenue This Year
$383.90
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$35.00
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.72
$0.87
52 Week High
$3.92
$2.99

Technical Indicators

Market Signals
Indicator
TUSK
BMEA
Relative Strength Index (RSI) 54.34 75.92
Support Level $2.12 $1.23
Resistance Level $3.49 $1.69
Average True Range (ATR) 0.18 0.11
MACD -0.01 0.04
Stochastic Oscillator 35.71 72.03

Price Performance

Historical Comparison
TUSK
BMEA

About TUSK Mammoth Energy Services Inc.

Mammoth Energy Services Inc is an integrated energy services company engaged in providing products and services to enable the exploration and development of North American onshore unconventional oil and natural gas reserves as well as the construction and repair of the electric grid for private utilities, public investor-owned utilities, and co-operative utilities through infrastructure services businesses. The company had three reportable segments, which includes rental services, infrastructure services, natural sand proppant services, accommodation services, and drilling services.

About BMEA Biomea Fusion Inc.

Biomea Fusion Inc is a a clinical stage diabetes and obesity medicines company focused on the discovery and development of oral, small molecule drugs to treat and improve the lives of patients with diabetes, obesity, and other metabolic diseases. It operate as an organization centered on two of its core drug candidate development programs: (i) icovamenib, its clinical program's drug candidate, currently being developed as an orally bioavailable, and selective, covalent inhibitor of menin in two clinical and multiple preclinical studies, investigating icovamenib's potential in type 1 and type 2 diabetes, as well as its impact in obesity, and (ii) BMF-650, its investigational, next-generation oral glucagon-like peptide-1 GLP-1 receptor agonist in development for the treatment of obesity.

Share on Social Networks: